Hey there, time traveller!
This article was published 2/6/2017 (1090 days ago), so information in it may no longer be current.
Delta 9 Bio-Tech has a binding agreement in place and is on track to obtain a public listing for its shares by the fall.
The Winnipeg licensed medical marijuana producer is in the process of organizing a reverse takeover of a Vancouver shell company called SVT Capital Corp.
It has closed a $3-million convertible debenture offering in a private placement and the company expects to raise an additional $3 million to $4 million around the time its shares are publicly listed.
The private placement valued the company at about $40 million.
The new entity created by the reverse takeover, which will remain a Winnipeg company, is to be called Delta 9 Cannabis Inc.
SVT Capital will be able to appoint one person to the board and the current Delta 9 entity will appoint four.
John Arbuthnot, who founded the company in partnership with his father, Bill Arbuthnot, said the goal is gain access to capital markets to be able to better fund growth.
"We want to broaden our investor base both with more retail investors as well as with more conventional institutional investors," he said. "Also having investors with more long-term vision toward the sector’s development will put us in a good spot."
When it opened in 2014, Delta 9 was one of the first cohort of 13 medical marijuana producers licensed by Health Canada.
(There are now 45 across the country, including another Winnipeg producer recently licensed called Bonify.)
Its modest 14,000 square feet of production space has grown rapidly.
A newly instituted hydroponic growing system in purpose-built shipping containers is expanding at the rate of up to 80 containers over the next year.
With the ability to stack the containers, its current facility has the capacity to expand to about 150,000 sq. ft. of production space.
Delta 9 is projected to do about $1.7 million in sales this year from a patient list of about 1,500 people.
The company will open its first retail clinic in an Osborne Village location in the next month.
Delta 9, like all the other medical marijuana producers, is positioning itself for federal legislation that will make the sale and use of recreational marijuana legal by next summer.
Martin Cash has been writing a column and business news at the Free Press since 1989. Over those years he’s written through a number of business cycles and the rise and fall (and rise) in fortunes of many local businesses.
Your support has enabled us to provide free access to stories about COVID-19 because we believe everyone deserves trusted and critical information during the pandemic.
Our readership has contributed additional funding to give Free Press online subscriptions to those that can’t afford one in these extraordinary times — giving new readers the opportunity to see beyond the headlines and connect with other stories about their community.
To those who have made donations, thank you.
To those able to give and share our journalism with others, please Pay it Forward.
The Free Press has shared COVID-19 stories free of charge because we believe everyone deserves access to trusted and critical information during the pandemic.
While we stand by this decision, it has undoubtedly affected our bottom line.
After nearly 150 years of reporting on our city, we don’t want to stop any time soon. With your support, we’ll be able to forge ahead with our journalistic mission.
If you believe in an independent, transparent, and democratic press, please consider subscribing today.
We understand that some readers cannot afford a subscription during these difficult times and invite them to apply for a free digital subscription through our Pay it Forward program.